These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28738111)

  • 1. Topical Clonazepam Solution for the Management of Burning Mouth Syndrome: A Retrospective Study.
    Kuten-Shorrer M; Treister NS; Stock S; Kelley JM; Ji YD; Woo SB; Lerman MA; Palmason S; Sonis ST; Villa A
    J Oral Facial Pain Headache; 2017 Summer; 31(3):257-263. PubMed ID: 28738111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerability of topical clonazepam solution for management of oral dysesthesia.
    Kuten-Shorrer M; Treister NS; Stock S; Kelley JM; Ji YD; Woo SB; Lerman MA; Palmason S; Sonis ST; Villa A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Aug; 124(2):146-151. PubMed ID: 28606830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical gabapentin solution for the management of burning mouth syndrome: A retrospective study.
    Gramacy A; Villa A
    PLoS One; 2023; 18(12):e0295559. PubMed ID: 38096135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined topical and systemic clonazepam therapy for the management of burning mouth syndrome: a retrospective pilot study.
    Amos K; Yeoh SC; Farah CS
    J Orofac Pain; 2011; 25(2):125-30. PubMed ID: 21528119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to topical clonazepam in patients with burning mouth syndrome: a clinical study.
    Rodríguez de Rivera Campillo E; López-López J; Chimenos-Küstner E
    Bull Group Int Rech Sci Stomatol Odontol; 2010 May; 49(1):19-29. PubMed ID: 22750263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical clonazepam for burning mouth syndrome: Is it efficacious in patients with anxiety or depression?
    Rossella I; Alessandro V; Naman R; Gary K; Hervé SY
    J Oral Rehabil; 2022 Jan; 49(1):54-61. PubMed ID: 34716948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain-relieving effects of clonazepam and amitriptyline in burning mouth syndrome: a retrospective study.
    Fenelon M; Quinque E; Arrive E; Catros S; Fricain JC
    Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1505-1511. PubMed ID: 28473243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome.
    Grushka M; Epstein J; Mott A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Nov; 86(5):557-61. PubMed ID: 9830647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy evaluation of clonazepam for symptom remission in burning mouth syndrome: a meta-analysis.
    Cui Y; Xu H; Chen FM; Liu JL; Jiang L; Zhou Y; Chen QM
    Oral Dis; 2016 Sep; 22(6):503-11. PubMed ID: 26680638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical clonazepam in stomatodynia: a randomised placebo-controlled study.
    Gremeau-Richard C; Woda A; Navez ML; Attal N; Bouhassira D; Gagnieu MC; Laluque JF; Picard P; Pionchon P; Tubert S
    Pain; 2004 Mar; 108(1-2):51-7. PubMed ID: 15109507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of acupuncture versus clonazepam in patients with burning mouth syndrome.
    Jurisic Kvesic A; Zavoreo I; Basic Kes V; Vucicevic Boras V; Ciliga D; Gabric D; Vrdoljak DV
    Acupunct Med; 2015 Aug; 33(4):289-92. PubMed ID: 25987645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind study on clonazepam in patients with burning mouth syndrome.
    Heckmann SM; Kirchner E; Grushka M; Wichmann MG; Hummel T
    Laryngoscope; 2012 Apr; 122(4):813-6. PubMed ID: 22344742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome predictors affecting the efficacy of clonazepam therapy for the management of burning mouth syndrome (BMS).
    Ko JY; Kim MJ; Lee SG; Kho HS
    Arch Gerontol Geriatr; 2012; 55(3):755-61. PubMed ID: 22040716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory burning mouth syndrome: clinical and paraclinical evaluation, comorbiities, treatment and outcome.
    Mitsikostas DD; Ljubisavljevic S; Deligianni CI
    J Headache Pain; 2017 Dec; 18(1):40. PubMed ID: 28357703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized pilot study to assess the safety and the value of low-level laser therapy versus clonazepam in patients with burning mouth syndrome.
    Arduino PG; Cafaro A; Garrone M; Gambino A; Cabras M; Romagnoli E; Broccoletti R
    Lasers Med Sci; 2016 May; 31(4):811-6. PubMed ID: 26873501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of clonazepam in patients with burning mouth syndrome and various symptoms or psychological conditions.
    Shin HI; Bang JI; Kim GJ; Kim MR; Sun DI; Kim SY
    Sci Rep; 2023 May; 13(1):7257. PubMed ID: 37142613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characterization and treatment outcome of patients with burning mouth syndrome.
    Hakeem A; Fitzpatrick SG; Bhattacharyya I; Islam MN; Cohen DM
    Gen Dent; 2018; 66(3):41-47. PubMed ID: 29714699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of reticular oral lichen planus patients with burning mouth syndrome-like oral symptoms: a pilot study.
    Adamo D; Mignogna MD; Pecoraro G; Aria M; Fortuna G
    J Dermatolog Treat; 2018 Sep; 29(6):623-629. PubMed ID: 29308937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burning mouth syndrome after taking clonazepam.
    Culhane NS; Hodle AD
    Ann Pharmacother; 2001; 35(7-8):874-6. PubMed ID: 11485137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effective perospirone augmentation with clonazepam for treatment-resistant burning mouth syndrome: A case report.
    Watanabe M; Takao C; Maeda C; Nayanar G; Tominaga R; Kimura Y; Tu TTH; Nagamine T; Toyofuku A
    Neuropsychopharmacol Rep; 2024 Jun; 44(2):464-467. PubMed ID: 38500267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.